Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer-Reference-Cited by-同舟云学术

Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer

Published:2020-01 Issue: Volume:51 Page:102547
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Jiménez-Vacas Juan M.,Herrero-Aguayo Vicente,Montero-Hidalgo Antonio J.,Gómez-Gómez Enrique,Fuentes-Fayos Antonio C.,León-González Antonio J.,Sáez-Martínez Prudencio,Alors-Pérez Emilia,Pedraza-Arévalo Sergio,González-Serrano Teresa,Reyes Oscar,Martínez-López Ana,Sánchez-Sánchez Rafael,Ventura Sebastián,Yubero-Serrano Elena M.,Requena-Tapia María J.,Castaño Justo P.,Gahete Manuel D.,Luque Raúl M.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference53 articles.

1. A day in the life of the spliceosome;Matera;Nat Rev Mol Cell Biol,2014

2. RNA mis-splicing in disease;Scotti;Nat Rev Genet,2016

3. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

4. The oncogenic role of the spliced somatostatin receptor sst5TMD4 variant in prostate cancer;Hormaechea-Agulla;Faseb J,2017

5. Changes in PKM2 associate with prostate cancer progression;Wong;Cancer Invest,2014

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the CLK2/SRSF9 splicing axis in prostate cancer leads to decreased ARV7 expression;Molecular Oncology;2024-09-11

2. Prognostic Significance of Elevated UCHL1, SNRNP200, and PAK4 Expression in High-Grade Clear Cell Renal Cell Carcinoma: Insights from LC-MS/MS Analysis and Immunohistochemical Validation;Cancers;2024-08-14

3. Splicing Machinery Is Impaired in Oral Squamous Cell Carcinomas and Linked to Key Pathophysiological Features;International Journal of Molecular Sciences;2024-06-25

4. Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors PRPF8 and RBMX as novel candidate actionable targets;Molecular Oncology;2024-05-24

5. Alternative splicing in prostate cancer progression and therapeutic resistance;Oncogene;2024-04-24